Sentence examples for secondary characterization from inspiring English sources

Then, the secondary characterization of the isolates was performed on the basis of their biochemical characteristics, which helped in distinguishing the isolates sharing similar morphological characteristics (Williams et al. 1989; Aneja et al. 2004).

Additional secondary characterization techniques can offer invaluable information about SCNP size and shape, including small angle neutron scattering (SANS) [3, 23], thorough DLS measurements [4, 23], atomic force microscopy (AFM) [11, 19, 20, 26, 29, 30, 33, 39, 42, 43, 56, 57], and transmission electron microscopy (TEM) [2, 7, 10, 11, 27, 38, 49].

After intratracheal instillation of rats to 0.8 20 mg/kg TiO2 (5 nm; TEM, no indication of secondary particle characterization), urine metabolite changes reflecting acute, transient metabolic disturbances of the liver and kidneys were only observed in the low-dose groups (Tang et al. 2010).

Applying 150 µg amorphous SiO2 NMs (10 and 80 nm, TEM; no secondary particle characterization) by intranasal instillation into both nostrils of rats for 90 days, the metabolomic profile of the serum, determined by NMR, exhibited significantly increased lactate, alanine, acetate, creatine, and choline coupled with a considerable decrease in the glucose level (Parveen et al. 2012).

In an in vitro study with human MRC- 5 fetal lung fibroblasts treated with up to 80.0 μg mL SiO2 NMs (average diameter 45 nm; no indication of secondary particle characterization), Huang et al. (2012) recorded dose-dependent decreases of various cellular amino acid levels as well as glutathione accompanied with increased phospholipid and urea concentrations (making use of GC MS and LC MS).

The workshop was subdivided into three sessions entitled "Thermodynamics and Fluid Characterization," "Secondary phases," and "Modeling approaches".

In these secondary forms, careful characterization of deposits can often help identify the underlying cause.

After primary isolation and characterization, secondary confirmation was performed at the Medical Research Council Laboratories, Gambia, or Sparrow Regional Laboratories, East Lansing, Michigan, USA.

Secondary objectives included characterization of toxicity, feasibility of such off-label prescription in routine practice and description of unique exceptional responses in particular sarcoma subtypes.

The performed sensitivity study indicates the need for a better characterization of secondary subsystem to substantially reduce the level of uncertainty.

Here, we provide a detailed characterization of secondary lymphedema in the mouse tail and correlate the evolution of tissue swelling to changes in tissue architecture, infiltration of immune cells, deposition of lipids, and proliferation and morphology of the lymphatic vessels.